Re: Mirtazapine in cancer patients
- PMID: 12565183
- DOI: 10.1016/s0885-3924(02)00595-x
Re: Mirtazapine in cancer patients
Comment on
-
An open-label, crossover trial of mirtazapine (15 and 30 mg) in cancer patients with pain and other distressing symptoms.J Pain Symptom Manage. 2002 May;23(5):442-7. doi: 10.1016/s0885-3924(02)00381-0. J Pain Symptom Manage. 2002. PMID: 12007762 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical